ReviewAdvances in therapy2026

Evaluating Cost-Effectiveness in Relation to the Supporting Clinical Evidence Across the Type 2 Diabetes Continuum: A Review of Metformin and SGLT2is.

Ian W Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.